PUSCEDDU, SARA

PUSCEDDU, SARA  

DIPARTIMENTO DI SCIENZE MEDICHE (attivo dal 01/01/2000 al 27/04/2012)  

Mostra records
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy : a phase II ITMO study 1-ago-2014 PUSCEDDU, SARAF. De BraudV. Mazzaferro + Article (author) -
Adjuvant radiotherapy for Merkel cell carcinoma: A systematic review and meta-analysis 1-mag-2019 Petrelli, FaustoGhidini, AntonioRusso, AlessandroCostanzo, AntonioSeghezzi, SilviaGhidini, MicheleVARRICCHIO, ANTONIOCABIDDU, MARYde Braud, FilippoPusceddu, Sara + Article (author) -
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 1-gen-2018 Pusceddu S.Barretta F.Botta L.De Braud F.Mazzaferro V.Massironi S. + Article (author) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 5-apr-2019 Pusceddu, SaraGhidini, MicheleCorti, FrancescaNiger, MonicaNichetti, FedericoCabiddu, Maryde Braud, FilippoPetrelli, Fausto + Article (author) -
Diagnosis and management of typical and atypical lung carcinoids 1-apr-2016 S. PuscedduL. DurantiG. PelosiF. de Braud + Article (author) -
Erratum: Real-world study of everolimus in advanced progressive neuroendocrine tumors (The Oncologist, (2014) 19, (966-974), 10.1634/theoncologist.2014-0037) 1-mag-2015 de Braud, FilippoFunaioli, ChiaraPusceddu, Sara + Article (author) -
Evolution in the treatment of gastroenteropancreatic-neuroendocrine neoplasms, focus on systemic therapeutic options : a systematic review 1-lug-2015 S. PuscedduF. De BraudV. Mazzaferro + Article (author) -
Fatal case of hepatic portal venous gas following palliative stenting and chemotherapy for occlusive advanced colorectal cancer 1-mar-2015 F. AgustoniS. PuscedduF. de Braud + Article (author) -
From biology to clinical experience : evolution in the knowledge of neuroendocrine tumours 1-gen-2009 S. PuscedduF. PietrantonioM. MaccauroE. Verzoni + Article (author) -
How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies 1-apr-2016 S. PuscedduF. De BraudC. VernieriA. Indini + Article (author) -
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 1-apr-2019 C. VernieriS. PuscedduG. FucàG. CentonzeL. CastagnoliE. FerrariA. AjaziS. CasolaM. FoianIV. MazzaferroG. PruneriF. de Braud + Article (author) -
Loss of succinate dehydrogenase subunit B (SDHB) as a prognostic factor in advanced ileal well-differentiated neuroendocrine tumors 1-set-2017 A. PellegrinelliS. PuscedduBRAMBILLA, CECILIA ELISABETTAV. MazzaferroF. de Braud + Article (author) -
Malignant pheochromocytoma and paraganglioma : future considerations for therapy 1-giu-2013 S. PuscedduV. MazzaferroF. De Braud + Article (author) -
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 1-gen-2018 S. PuscedduC. VernieriS. MassironiF. CavalcoliV. MazzaferroF. de Braud + Article (author) -
Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes 1-mag-2016 S. PuscedduC. VernieriV. MazzaferroF. De Braud + Article (author) -
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms 1-ott-2019 Pusceddu, SaraCotsoglou, ChristianMazzaferro, Vincenzode Braud, FilippoPruneri, Giancarlo + Article (author) -
Pancreatic well-differentiated neuroendocrine neoplasms (PWDNENS) : What place for everolimus and sunitinib derived from esmo clinical practice guidelines in the therapeutic algorithm? 1-mag-2013 S. PuscedduF. De Braud + Article (author) -
Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors 1-gen-2016 S. PuscedduIMBIMBO, MARTINAF. de Braud + Article (author) -
Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up 1-ago-2016 C. VernieriS. PuscedduF. De Braud + Article (author) -
Primary tumour resection may improve survival in functional well-differentiated neuroendocrine tumours metastatic to the liver 1-gen-2017 CITTERIO, DAVIDES. PuscedduJ. CoppaM. BonginiF. DebraudV. Mazzaferro + Article (author) -